| Mutational heterogeneity in cancer and the search for new cancer-associated genes MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ... Nature 499 (7457), 214-218, 2013 | 5829 | 2013 |
| Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ... Nature genetics 44 (6), 685-689, 2012 | 1741 | 2012 |
| Punctuated evolution of prostate cancer genomes SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ... Cell 153 (3), 666-677, 2013 | 1417 | 2013 |
| Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma JA Perry, A Kiezun, P Tonzi, EM Van Allen, SL Carter, SC Baca, ... Proceedings of the National Academy of Sciences 111 (51), E5564-E5573, 2014 | 438 | 2014 |
| Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis AM Dulak, SE Schumacher, J Van Lieshout, Y Imamura, C Fox, B Shim, ... Cancer research 72 (17), 4383-4393, 2012 | 307 | 2012 |
| Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer JPP Theurillat, ND Udeshi, WJ Errington, T Svinkina, SC Baca, M Pop, ... Science 346 (6205), 85-89, 2014 | 236 | 2014 |
| Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes PV Nuzzo, JE Berchuck, K Korthauer, S Spisak, AH Nassar, S Abou Alaiwi, ... Nature medicine 26 (7), 1041-1043, 2020 | 211 | 2020 |
| Prostate cancer reactivates developmental epigenomic programs during metastatic progression MM Pomerantz, X Qiu, Y Zhu, DY Takeda, W Pan, SC Baca, A Gusev, ... Nature genetics 52 (8), 790-799, 2020 | 187 | 2020 |
| EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer KL Morel, AV Sheahan, DL Burkhart, SC Baca, N Boufaied, Y Liu, X Qiu, ... Nature cancer 2 (4), 444-456, 2021 | 143 | 2021 |
| Unraveling the clonal hierarchy of somatic genomic aberrations D Prandi, SC Baca, A Romanel, CE Barbieri, JM Mosquera, J Fontugne, ... Genome biology 15, 1-16, 2014 | 108 | 2014 |
| Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ... Nature communications 12 (1), 808, 2021 | 104 | 2021 |
| CDK7 inhibition suppresses castration-resistant prostate cancer through MED1 inactivation R Rasool, R Natesan, Q Deng, S Aras, P Lal, S Sander Effron, ... Cancer discovery 9 (11), 1538-1555, 2019 | 94 | 2019 |
| Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer SC Baca, DY Takeda, JH Seo, J Hwang, SY Ku, R Arafeh, T Arnoff, ... Nature communications 12 (1), 1979, 2021 | 93 | 2021 |
| Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer P Cejas, Y Xie, A Font-Tello, K Lim, S Syamala, X Qiu, AK Tewari, N Shah, ... Nature communications 12 (1), 5775, 2021 | 78 | 2021 |
| Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes SC Baca, KS Wong, KC Strickland, HT Heller, MI Kim, JA Barletta, ... Cancer Cytopathology 125 (5), 313-322, 2017 | 69 | 2017 |
| Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors S Abou Alaiwi, AH Nassar, W Xie, Z Bakouny, JE Berchuck, DA Braun, ... Cancer immunology research 8 (8), 1075-1084, 2020 | 63 | 2020 |
| The genomic landscape of prostate cancer SC Baca, LA Garraway Frontiers in endocrinology 3, 69, 2012 | 57 | 2012 |
| HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer X Lu, K Fong, G Gritsina, F Wang, SC Baca, LT Brea, JE Berchuck, ... Nature genetics 54 (5), 670-683, 2022 | 50 | 2022 |
| ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer S Nouruzi, D Ganguli, N Tabrizian, M Kobelev, O Sivak, T Namekawa, ... Nature Communications 13 (1), 2282, 2022 | 50 | 2022 |
| H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility C Giambartolomei, JH Seo, T Schwarz, MK Freund, RD Johnson, ... The American Journal of Human Genetics 108 (12), 2284-2300, 2021 | 38 | 2021 |
Levi GarrawayAssociate Professor of Medicine, Harvard Medical School在 dfci.harvard.edu 的电子邮件经过验证
